Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.15%8.56M | -41.95%7.7M | -16.51%13.26M | -14.46%15.89M | 31.86%18.57M | -26.55%14.09M | 0.39%19.18M | 20.39%19.1M | -2.15%15.87M | 10.27%16.22M |
| Operating revenue | 11.15%8.56M | -41.95%7.7M | -16.51%13.26M | -14.46%15.89M | 31.86%18.57M | -26.55%14.09M | 0.39%19.18M | 20.39%19.1M | -2.15%15.87M | 10.27%16.22M |
| Cost of revenue | 7.00%5.07M | -46.25%4.74M | -14.90%8.82M | -23.27%10.36M | 6.65%13.5M | -28.83%12.66M | 11.90%17.79M | 31.47%15.9M | 62.16%12.09M | 6.55%7.46M |
| Gross profit | 17.79%3.49M | -33.43%2.96M | -19.52%4.45M | 9.00%5.53M | 256.07%5.07M | 2.70%1.42M | -56.73%1.39M | -15.12%3.2M | -56.91%3.77M | 13.65%8.76M |
| Operating expense | -10.30%4.64M | -3.15%5.17M | 1.89%5.34M | -12.19%5.24M | 7.78%5.97M | -35.13%5.54M | -14.13%8.53M | 7.14%9.94M | -3.46%9.28M | 15.08%9.61M |
| Selling and administrative expenses | -7.70%1.99M | -10.83%2.15M | 2.92%2.41M | -1.36%2.34M | 2.84%2.38M | -31.04%2.31M | 14.04%3.35M | -38.76%2.94M | -36.26%4.8M | 10.06%7.53M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 10.75%1.14M |
| -General and administrative expense | -7.70%1.99M | -10.83%2.15M | 2.92%2.41M | -1.36%2.34M | 2.84%2.38M | -31.04%2.31M | 14.04%3.35M | -38.76%2.94M | -24.83%4.8M | 9.94%6.38M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 304.27%57.24K |
| Depreciation amortization depletion | 30.25%619.21K | 30.86%475.42K | 33.56%363.31K | -24.25%272.01K | -23.04%359.12K | -65.58%466.64K | -54.77%1.36M | 66.35%3M | 69.96%1.8M | 19.83%1.06M |
| -Depreciation and amortization | 30.25%619.21K | 30.86%475.42K | 33.56%363.31K | -24.25%272.01K | -23.04%359.12K | -65.58%466.64K | -54.77%1.36M | 66.35%3M | 69.96%1.8M | 19.83%1.06M |
| Provision for doubtful accounts | ---- | ---- | 146.69%15K | 75.75%-32.13K | -109.44%-132.45K | 65.35%1.4M | 121.49%848.33K | --383.02K | ---- | ---- |
| Other operating expenses | -20.08%2.03M | -0.15%2.54M | -4.06%2.55M | -21.05%2.66M | 148.14%3.36M | -54.50%1.36M | -17.68%2.98M | 35.26%3.62M | 177.70%2.68M | 57.75%963.42K |
| Operating profit | 47.93%-1.15M | -147.83%-2.21M | -411.87%-891.99K | 131.87%286.01K | 78.18%-897.48K | 42.47%-4.11M | -6.14%-7.15M | -22.41%-6.73M | -547.11%-5.5M | -32.25%-850.17K |
| Net non-operating interest income (expenses) | -116.01%-433.94K | -82.36%-200.88K | -67.50%-110.16K | -40.34%-65.77K | -55.90%-46.86K | -182.77%-30.06K | 190.84%36.32K | 47.21%-39.98K | -157.99%-75.73K | 183.01%130.6K |
| Non-operating interest income | -91.74%2.08K | 99.88%25.18K | --12.6K | ---- | -73.73%2.57K | -76.43%9.8K | 532.09%41.57K | -82.35%6.58K | -74.93%37.26K | 191.19%148.62K |
| Non-operating interest expense | 117.52%405.68K | 79.61%186.5K | 190.21%103.83K | 593.10%35.78K | -87.05%5.16K | 659.04%39.86K | -88.72%5.25K | -58.80%46.55K | 698.09%112.99K | 8,975.64%14.16K |
| Total other finance cost | -23.32%30.34K | 109.11%39.56K | -36.91%18.92K | -32.27%29.99K | --44.27K | ---- | ---- | ---- | ---- | -18.45%3.86K |
| Other net income (expenses) | -37.96%-115.63K | -250.10%-83.82K | 141.68%55.84K | -113.76%-133.97K | -31.20%973.54K | 159.26%1.42M | 62.64%-2.39M | -1,047.59%-6.39M | -80.37%674.44K | 166.90%3.44M |
| Special income (charges) | -16.46%-120K | -130.84%-103.04K | -146.16%-44.64K | -51.42%96.71K | --199.05K | ---- | 42.26%-4.16M | -1,287.53%-7.21M | ---519.58K | ---- |
| -Less:Impairment of capital assets | 16.46%120K | 130.84%103.04K | 146.16%44.64K | 51.42%-96.71K | ---199.05K | ---- | -42.26%4.16M | 1,287.53%7.21M | --519.58K | ---- |
| Other non-operating income (expenses) | -77.29%4.37K | -80.87%19.22K | 143.56%100.48K | -129.78%-230.67K | -45.27%774.49K | -20.28%1.42M | 116.86%1.77M | -31.45%818.46K | -65.25%1.19M | 166.90%3.44M |
| Income before tax | 31.45%-1.7M | -163.93%-2.48M | -1,189.44%-939.98K | 195.50%86.28K | 101.07%29.2K | 71.29%-2.73M | 27.85%-9.5M | -168.53%-13.17M | -280.52%-4.9M | 293.33%2.72M |
| Income tax | 0 | 2.47K | 0 | 0 | 7.83%4.35K | 106.89%4.04K | 96.71%-58.63K | -288.46%-1.78M | -64.79%945.08K | 365.24%2.68M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 31.52%-1.7M | -164.19%-2.48M | -1,189.44%-939.98K | 247.29%86.28K | 100.91%24.84K | 71.07%-2.73M | 17.07%-9.44M | -94.67%-11.38M | -18,630.56%-5.85M | -72.20%31.56K |
| Net income continuous operations | 31.52%-1.7M | -164.19%-2.48M | -1,189.44%-939.98K | 247.29%86.28K | 100.91%24.84K | 71.07%-2.73M | 17.07%-9.44M | -94.67%-11.38M | -18,630.56%-5.85M | -72.20%31.56K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 31.52%-1.7M | -164.19%-2.48M | -1,189.44%-939.98K | 247.29%86.28K | 100.91%24.84K | 71.07%-2.73M | 17.07%-9.44M | -94.67%-11.38M | -18,630.56%-5.85M | -72.20%31.56K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 31.52%-1.7M | -164.19%-2.48M | -1,189.44%-939.98K | 247.29%86.28K | 100.91%24.84K | 71.07%-2.73M | 17.07%-9.44M | -94.67%-11.38M | -18,630.56%-5.85M | -72.20%31.56K |
| Diluted earnings per share | 24.49%-0.0037 | -166.74%-0.0049 | -801.15%-0.0018 | 208.24%0.0003 | 100.78%0.0001 | 71.04%-0.0109 | 49.31%-0.0377 | -36.68%-0.0744 | -21,784.86%-0.0544 | -78.55%0.0003 |
| Basic earnings per share | 24.49%-0.0037 | -166.74%-0.0049 | -801.15%-0.0018 | 208.24%0.0003 | 100.78%0.0001 | 71.04%-0.0109 | 49.31%-0.0377 | -36.68%-0.0744 | -21,784.86%-0.0544 | -78.55%0.0003 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |